V-Bio Ventures
V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed V-Bio Ventures Information
Geographic Data
Address: Rijvisschestraat 126
City: Gent
State: flemish brabant
Zip: 9052
Country: BE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$366M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agricultural sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2022 | AstriVax | Seed Round | 30M |
| 12/2021 | Corteria Pharmaceuticals | Seed Round | 0 |
| 9/2018 | Coave Therapeutics | Series B | 26.3M |
| 12/2019 | Augustine Therapeutics | Seed Round | 4.7M |
| 2/2016 | Confo Therapeutics | Seed Round | 7.4M |
| 1/2017 | OCTIMET Oncology | Series A | 12M |
| 4/2021 | Protealis | Series A | 0 |
| 7/2021 | Coave Therapeutics | Series B | 0 |
| 11/2018 | Precirix | Series A | 41.9M |
| 4/2021 | Aphea.Bio | Series B | 0 |
| 10/2020 | Animab | Seed Round | 0 |
| 6/2017 | Aphea.Bio | Series A | 0 |
| 10/2022 | Sibylla Biotech | Series A | 0 |
| 3/2020 | Orionis Biosciences | Series B | - |
| 8/2020 | Biodol Therapeutics | Series A | 5.4M |
| 2/2018 | Syndesi Therapeutics | Series A | 21.3M |
| 9/2020 | Syndesi Therapeutics | Series A | 7M |
| 7/2021 | Muna Therapeutics | Series A | 0 |
| 3/2021 | Oxular | Series B | 37M |
| 1/2020 | RootWave | Series A | 0 |
| 4/2016 | Orionis Biosciences | Series A | - |
| 7/2020 | ExeVir Bio | Series A | 0 |
| 7/2016 | Oxular | Series A | 20.6M |
| 3/2022 | Precirix | Series B | 0 |
| 5/2019 | Confo Therapeutics | Series A | 33.6M |
| 5/2023 | Dualyx | Series A | 0 |
| 4/2019 | AgomAb Therapeutics | Series A | 23.6M |
| 3/2021 | AgomAb Therapeutics | Series B | 0 |
| 3/2022 | Precirix | Series B | 0 |
| 12/2021 | Corteria Pharmaceuticals | Seed Round | 0 |
| 7/2021 | Coave Therapeutics | Series B | 0 |
| 7/2021 | Muna Therapeutics | Series A | 0 |
| 4/2021 | Aphea.Bio | Series B | 0 |
| 4/2021 | Protealis | Series A | 0 |
| 3/2021 | AgomAb Therapeutics | Series B | 0 |
| 3/2021 | Oxular | Series B | 0 |
| 10/2020 | Animab | Seed Round | 0 |
| 9/2020 | Syndesi Therapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
